Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ISRCTN79202365) titled 'Deferred registration: Quotient Sciences Code: QSC302725' on June 23.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Phase I trial in healthy volunteers
Primary Sponsor: Agomab Spain, S.L.U.
Condition:
Healthy volunteers
Other
Intervention:
This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date.
Recruitment Status: Recruiting
Phase: Phase I
Date of First Enrollment: 24/0...